Cargando…

Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy

Mutations in the ferritin light chain (FTL) gene cause the neurodegenerative disease neuroferritinopathy or hereditary ferritinopathy (HF). HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic iron-containing ferritin inclusion bodies (IBs) in glia and neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garringer, Holly J., Irimia, Jose M., Li, Wei, Goodwin, Charles B., Richine, Briana, Acton, Anthony, Chan, Rebecca J., Peacock, Munro, Muhoberac, Barry B., Ghetti, Bernardino, Vidal, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004847/ https://www.ncbi.nlm.nih.gov/pubmed/27574973 http://dx.doi.org/10.1371/journal.pone.0161341

Ejemplares similares

Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration
por: Muhoberac, Barry B., et al.
Publicado: (2019)

Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy
por: Barbeito, Ana G, et al.
Publicado: (2010)

Systemic and Cerebral Iron Homeostasis in Ferritin Knock-Out Mice
por: Li, Wei, et al.
Publicado: (2015)

Cryo-EM structures and functional characterization of homo- and heteropolymers of human ferritin variants
por: Irimia-Dominguez, Jose, et al.
Publicado: (2020)

Using substantial reductant concentration with chelation therapy to enhance small aggregate dispersal, iron mobilization, and its clearance in neurodegenerative diseases
por: Muhoberac, Barry B.
Publicado: (2022)

Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI(2)/Tau Transgenic Mice
por: Garringer, Holly J., et al.
Publicado: (2013)

Structure of Tau filaments in Prion protein amyloidoses
por: Hallinan, Grace I., et al.
Publicado: (2021)

Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold
por: Falcon, Benjamin, et al.
Publicado: (2018)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Abnormal iron homeostasis and neurodegeneration
por: Muhoberac, Barry B., et al.
Publicado: (2013)

Structures of filaments from Pick’s disease reveal a novel tau protein fold
por: Falcon, Benjamin, et al.
Publicado: (2018)

Generation of a novel murine model of Aβ deposition based on the expression of human wild-type amyloid precursor protein gene
por: Vidal, Rubén, et al.
Publicado: (2012)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)
por: Cracco, Laura, et al.
Publicado: (2022)

Cross-β helical filaments of Tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia
por: Hoq, Md. Rejaul, et al.
Publicado: (2023)

Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
por: Falcon, Benjamin, et al.
Publicado: (2019)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
por: Arseni, Diana, et al.
Publicado: (2023)

EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
por: Fulgenzi, Alessandro, et al.
Publicado: (2020)

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
por: Ben-Shushan, Shira, et al.
Publicado: (2021)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Mutation ∆K281 in MAPT causes Pick’s disease
por: Schweighauser, Manuel, et al.
Publicado: (2023)

Cerebral Amyloid Angiopathy and Parenchymal Amyloid Deposition in Transgenic Mice Expressing the Danish Mutant Form of Human BRI(2)
por: Vidal, Ruben, et al.
Publicado: (2008)

Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration
por: Baraibar, Martin A., et al.
Publicado: (2008)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
por: Nuñez, Marco T., et al.
Publicado: (2018)

Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
por: Kwiatkowski, Janet L
Publicado: (2011)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
por: Makis, Alexandros, et al.
Publicado: (2013)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach
por: Islam, Sufia, et al.
Publicado: (2022)

Novel tau filament fold in corticobasal degeneration
por: Zhang, Wenjuan, et al.
Publicado: (2020)

Cryo-EM structures of Aβ40 filaments from the leptomeninges of individuals with Alzheimer’s disease and cerebral amyloid angiopathy
por: Yang, Yang, et al.
Publicado: (2023)

Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Correction to: Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008)

Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
por: Ghosh, Kanjaksha, et al.
Publicado: (2018)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
por: Dijiong, Wu, et al.
Publicado: (2019)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy
por: van Hattem, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_auk6smbk00pat7ulrko20sb2dg